Cover Image for CBS Women’s Circle and Bay Area Alumni Club Presents: Healthcare AI: Investing/Building for Better Outcomes
Cover Image for CBS Women’s Circle and Bay Area Alumni Club Presents: Healthcare AI: Investing/Building for Better Outcomes
Hosted By
14 Went

CBS Women’s Circle and Bay Area Alumni Club Presents: Healthcare AI: Investing/Building for Better Outcomes

Hosted by Sooin Kwon
Get Tickets
Past Event
Ticket Price
$15.00
Welcome! To join the event, please get your ticket below.
About Event

​VC Panel discussion, followed by Q&A, and networking and light refreshments in an intimate setting. $15 fee per participant. Max 40 participants.

​Location: 2000 Sierra Point Parkway, Brisbane, CA

​Host: Sooin Kwon, CBS 2001, Chief Business Officer, Lakefront Biotherapeutics

​

​Moderator: Noam Krantz, CBS 2001, SVP Corporate Development, Guardant Health

  • ​Noam Krantz is the Senior Vice President of Corporate Development at Guardant Health, where he oversees the company’s mergers and acquisitions, licensing, and investment strategies. He leads long-range planning for the organization and has extensive experience in medtech business development. Before Guardant Health, Noam held key roles at Johnson & Johnson, including at Ethicon Inc. and J&J Development Corp., and was part of Johnson & Johnson's medtech deal committee. He also led corporate development and investor relations at Mentor Corporation and Inamed Corporation, both acquired by major health companies.

​

  • ​Sooin Kwon is Chief Business Officer at Lakefront Biotherapeutics. She joined the company in August 2025. Prior to Lakefront, she was a Partner at MTS Health Partners, where she advised on financing and strategic transactions for biotech and pharmaceutical companies. Earlier, she held senior roles at Banc of America Securities, Merlin Biomed, UBS, and Equinox Group.

  • ​Panelists:

  • ​Dr. Kiersten Stead

​o   Kiersten is a co-founder of DCVC Bio and a scientist-investor dedicated to building deep-tech platforms in the life sciences. She partners closely with entre­pre­neurs — often at the very beginning — to help launch companies on solid scientific and strategic foundations and then supports them as they grow through each stage of development.

​o   Kiersten has been investing since 2011. Before joining DCVC Bio, she worked as a scientist and co-founded several life-science companies over the course of her career. She currently serves on multiple company boards and contributes to the broader scientific community as a director of nonprofit orga­ni­za­tions such as Keystone Symposia.

​

  • ​Dr. Carlos Solorzano

​o   Carlos is a Principal for Ally Bridge Group’s private equity strategy, focused on investments in biotech. Prior to joining Ally Bridge Group in 2024, Carlos was an Investment professional at Section 32 and Pivotal bioVenture Partners, focused on private biotech companies. Before his career in private equity, Carlos was in the business development and corporate strategy team at Ultragenyx, and prior to that as an equity research Analyst at Deutsche Bank and Oppenheimer.

​Carlos currently or previously served on the Board of Directors for Ensho Therapeutics, Shoreline Biosciences, and Sonoma Biotherapeutics.

  • ​Dr. Kristin Gleitsman

​o   Kristin Gleitsman, PhD, is the Biology Fellow at Fellows Fund, an early-stage venture firm backing founders building frontier AI companies. Her work at Fellows Fund focuses on evaluating and supporting seed-stage companies at the intersection of AI, healthcare, and life sciences. She is also Chief Science Officer at EIGEN Bio, an AI-native biotechnology company using human molecular response data to improve therapeutic discovery and development.

​Kristin has spent more than two decades building and leading R&D organizations across biotechnology and diagnostics, including senior leadership roles at Guardant Health, Veracyte, and Pacific Biosciences. Across her investing and operating work, she focuses on a central question: where can AI create genuinely new scientific and clinical capability today, and what new possibilities might AI unlock in the future?

​

​

​

Location
2000 Sierra Point Pkwy
Brisbane, CA 94005, USA
Hosted By
14 Went